TOP NEWS

Debut Finds $40M In New Funding

San Diego-based Debut, which is applying synthetic biology to the fragrance industry, says it has raised $40M in a Series B funding round. The company said the funding was led by BOLD, the venture capital fund of L'Oreal. Debut says it is developing "bio-based formulas" for fragrance brands, which "can replicate the scent signature and precise characteristics of natural ingredients, including those that are structurally complex, difficult to source, and only exist in trace amounts in nature." The company's founder and CEO is Joshua Britten, Ph.D.